Figure 1
Flowchart of participants from examination to A/T/N classification and evaluation of olfactory discrimination. CSF cerebrospinal fluid; DLB diffuse Lewy body disease; FTD frontotemporal dementia; MCI mild cognitive impairment; AD Alzheimer's disease; ROC receiver operating characteristic; Aβ amyloid-β; p-Tau phosphorylated Tau; t-Tau total Tau; A+ amyloid-positive individuals; A− amyloid-negative individuals; T+ phosphorylated Tau-positive individuals; T− phosphorylated Tau-negative individuals; T+ total Tau-positive individuals; T− total Tau-negative individuals; SNAP suspected non-Alzheimer’s disease pathophysiology; ApoE apolipoprotein E; MMSE Mini-Mental State Examination; AUC area under the curve.
